JNJ Johnson & Johnson
Johnson & Johnson (JNJ) is expected to report earnings on October 19, 2026, before the market open. The consensus earnings estimate is $2.95 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +4.1% since its last earnings release on July 15, 2026.
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About Johnson & Johnson
Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of products in the health care field within its Consumer, Pharmaceutical and Medical Devices, and Diagnostics business segments.
Sector
Healthcare
Industry
Drug Manufacturers / Major
Held By 10 ETFs, by dollar flow
- OEF iShares S&P 100 ETF
- XLG Invesco S&P 500 Top 50 ETF
- IOO iShares Global 100 ETF
- DIA SPDR Dow Jones Industrial Average ETF
- HDV iShares Core High Dividend ETF
- XLV Health Care Select Sector SPDR Fund
- IYH iShares U.S. Healthcare ETF
- IXJ iShares Global Healthcare ETF
- PPH VanEck Pharmaceutical ETF
- XPH SPDR S&P Pharmaceuticals ETF